Cambridge Major Laboratories, Inc. history

In 1965, the CRA and the City of Cambridge adopted the Kendall Square Urban Renewal Plan (KSURP) with a primary goal of providing to NASA land for an Electronic Research Center.

1967 CRA begins concept planning for 13-acre “Golden Triangle” to be privately developed.

1969 Developer interest solicited for Golden Triangle development.

In 1970, NASA abandoned its operations in the project and transferred its interests to the United States Department of Transportation, to create the Volpe Transportation Research Center.

1971 DOT agrees to release its rights to the “surplus NASA” land north of Broadway and west of Sixth Street, an 11-acre site; CRA begins re-planning efforts.

1972 Revised concept plan prepared by the CRA and presented to developers, City Council and Board.

1973 City council reviews CRA plan for job-intensive uses on surplus NASA land and mixed-use development on the Triangle; plan is rejected and Kendall Square Task Force appointed by mayor Acherman.

1974 Task Force recommendation of light industrial uses on Parcel 2 (surplus NASA land) rejected and the Neighborhood Plan for mixed use adopted by the Council.

1976 CRA brings in Urban Land Institute panel to review the project and recommendations for mixed use are made to the City; GSA approves the surplus NASA land transfer; EIS completed.

1979 CRA executes development agreement with Boston Properties, anticipating 1,500,000 square feet of privately financed development on the Triangle.

Since its founding in 1981, CIL and its people have been committed to high-quality stable isotope-labeled products, superior customer service, innovative new products and a breadth of product lines.

1983 Four Cambridge Center fully leased and 863-car garage between Four and Five Cambridge Center opens for parking in April, both managed by Boston Properties; construction on Fourteen Cambridge Center completed in June and under management by Biogen.

1988 Construction completed by CRA on major transit plaza between One and Three Cambridge Center, providing setting for outdoor dining and scheduled activities, owned by CRA and programmed and maintained by Boston Properties.

1993 CRA approves construction on 148,228 square-foot, 6-story biotechnology lab and office building at Twelve Cambridge Center commences by Biogen, under terms of ground lease with Boston Properties; Planning Board and City Council on Zoning and Urban Renewal Plan Amendments.

2000 Building moratorium adopted by the City of Cambridge; City undertakes comprehensive study of land use.

2002 CRA convenes an advisory ground known as the Housing and Open Space Coalition, with a charge to present to the Authority recommendations for Parcel 1; approval by the Executive Office of Environmental Affairs and Department of Housing and Community Development of Parcel 3 development (i.e.

2004 Biogen announces plan to proceed with expansion of Twelve Cambridge Center; Board of Zoning Appeals approves variances to allow Boston Properties to proceed with Seven Cambridge Center for the Broad Institute and a parking garage.

2006 Congressional approval of a $750,000 appropriation for street improvements in Kendall Square; and $1 million for open-space development.

2009 Funds from an earlier earmark were transferred to improvements on Broadway identified by the City of Cambridge.

2013 Boston Properties completes the construction of 17 Cambridge Center at 300 Binney St, a 188,000 square-foot office building designed to accommodate future research lab use.

MXD District Signage Review (September 2014)

As of December 21st, 2015, City Council passed a major amendment to the KSURP in order to accommodate additional development planned for by the City of Cambridge's K2 Planning Process.

2016 The DHCD finalized the 10th Amendment of the KSURP providing for an additional 600,000 sf of office and lab space and 400,000 sf of residential development consistent with the K2 Plan.